Isik E, Etevenon P, Verdeaux J, Bioux P, Pidoux B, Verdeaux G
Rev Electroencephalogr Neurophysiol Clin. 1982 Apr;12(1):86-95. doi: 10.1016/s0370-4475(82)80013-0.
Eighty-seven EEG recordings were obtained from 9 healthy volunteers, medical students who were part of a controlled, double-blind, randomized study. After a first control recording, they received orally, at 1 week interval, either 3 placebos or 3 compounds: yohimbine chlorhydrate (4 mg), propranolol (40 mg), a psychotropic compound in experimentation. The polygraphic recordings were obtained 2 or 6 h after placebos or active compounds. Four EEG channels were recorded simultaneously (T4-C4, T3-C3, P4-O2, P3-O1). The EEGs were sampled at 200 Hz, for 120 successive epochs, free of artifacts. The recordings of 5 min were then submitted to spectral analysis followed by data reduction providing characteristic spectral parameters. A descriptive questionnaire of EEG made of 100 items was filled out by two electroencephalographists for each of 87 recordings. The items, with dichotomic choices, described 4 EEG frequency bands: delta, theta, alpha, and fast frequencies (beta). For each frequency band the following was evaluated: frequency, amplitude, asymmetry, morphology, relative abundance, irregularity, lability of frequency, diffusion, dominant localization, EMG activity and superposition of rhythms. The number of periods of drowsiness in 5 min and fluctuations of rhythms were also ascertained in the same way. The items were coded on punch cards and submitted to a first analysis of correspondences. The 3 factorial planes were plotted with the projections of each item together with the centers of gravity of placebos and treatments. The first factor can be interpreted as a bipolar axis 'mental activation-diffused vigilance', the first pole being characterized by a 'beta cluster' and the second by alpha and theta superimposed clusters. The second factor can be also considered as a bipolar axis 'drowsiness -quiet wakefulness', the first pole being characterized by a 'theta cluster' and a larger 'delta cluster' containing a smaller 'alpha cluster' of labile alpha rhythm intermingled with slower rhythms. In respect to the barycentric centers of gravity, yohimbine and propranolol are opposed to the placebo center along the factor-two axis. This may be considered as an 'anti-sedation effect'. However, along the first factor axis, the propranolol center can be associated with a greater diffusion of vigilance than the yohimbine center.
从9名健康志愿者(参与一项对照、双盲、随机研究的医科学生)身上获取了87份脑电图记录。在首次对照记录后,他们每隔1周口服3种安慰剂或3种化合物:盐酸育亨宾(4毫克)、普萘洛尔(40毫克),一种正在试验中的精神类化合物。在服用安慰剂或活性化合物后2小时或6小时进行多导记录。同时记录4个脑电图通道(T4-C4、T3-C3、P4-O2、P3-O1)。脑电图以200赫兹的频率采样,连续采样120个时段,无伪迹。然后对5分钟的记录进行频谱分析,随后进行数据简化,得出特征频谱参数。两位脑电图专家针对87份记录中的每一份填写了一份由100项内容组成的脑电图描述性问卷。这些项目有二分法选择,描述了4个脑电图频段:δ波、θ波、α波和快波频率(β波)。对于每个频段,评估了以下内容:频率、振幅、不对称性、形态、相对丰度、不规则性、频率的不稳定性、扩散、优势定位、肌电图活动和节律叠加。同样确定了5分钟内的嗜睡期数量和节律波动情况。这些项目编码在穿孔卡片上,并进行了首次对应分析。绘制了3个因子平面,其中每个项目的投影以及安慰剂和治疗的重心都在图上。第一个因子可解释为一个双极轴“精神激活-弥散性警觉”,第一极的特征是一个“β波簇”,第二极的特征是α波和θ波叠加簇。第二个因子也可视为一个双极轴“嗜睡-安静觉醒”,第一极的特征是一个“θ波簇”和一个较大的“δ波簇”,其中包含一个较小的不稳定α节律的“α波簇”,与较慢的节律混合在一起。就重心而言,育亨宾和普萘洛尔在因子二轴上与安慰剂中心相对。这可被视为一种“抗镇静作用”。然而,沿着第一个因子轴,普萘洛尔中心比育亨宾中心与更大的警觉扩散相关联。